Free Trial

Aurora Cannabis (OTCMKTS:ACBFF) Trading Up 6.2% - Still a Buy?

Aurora Cannabis logo with Medical background

Key Points

  • Aurora Cannabis Inc shares increased by 6.2% during mid-day trading, closing at $6.17 after trading as high as $6.51.
  • The company's market capitalization stands at $5.93 billion with a price-to-earnings ratio of 51.42.
  • Aurora Cannabis is actively involved in the production and distribution of medical cannabis, being vertically integrated across all segments of the cannabis value chain.
  • Interested in Aurora Cannabis? Here are five stocks we like better.

Shares of Aurora Cannabis Inc (OTCMKTS:ACBFF - Get Free Report) were up 6.2% during mid-day trading on Wednesday . The stock traded as high as $6.51 and last traded at $6.17. Approximately 3,664,054 shares changed hands during trading, a decline of 13% from the average daily volume of 4,224,181 shares. The stock had previously closed at $5.81.

Aurora Cannabis Trading Up 6.2%

The firm has a market capitalization of $5.93 billion and a price-to-earnings ratio of 51.42. The company has a 50-day moving average of $5.11 and a 200-day moving average of $4.86.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aurora Cannabis Right Now?

Before you consider Aurora Cannabis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.

While Aurora Cannabis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.